State Street’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.38M | Sell |
1,218,366
-34,074
| -3% | -$234K | ﹤0.01% | 2687 |
|
2025
Q1 | $3.61M | Buy |
1,252,440
+7,121
| +0.6% | +$20.5K | ﹤0.01% | 3013 |
|
2024
Q4 | $5.85M | Sell |
1,245,319
-434,910
| -26% | -$2.04M | ﹤0.01% | 2891 |
|
2024
Q3 | $6M | Buy |
1,680,229
+638,955
| +61% | +$2.28M | ﹤0.01% | 2875 |
|
2024
Q2 | $6.46M | Buy |
1,041,274
+784,413
| +305% | +$4.86M | ﹤0.01% | 2808 |
|
2024
Q1 | $2.42M | Buy |
256,861
+73,714
| +40% | +$696K | ﹤0.01% | 3219 |
|
2023
Q4 | $1.24M | Hold |
183,147
| – | – | ﹤0.01% | 3437 |
|
2023
Q3 | $813K | Sell |
183,147
-22,800
| -11% | -$101K | ﹤0.01% | 3574 |
|
2023
Q2 | $680K | Sell |
205,947
-759,641
| -79% | -$2.51M | ﹤0.01% | 3631 |
|
2023
Q1 | $2.75M | Buy |
965,588
+185,174
| +24% | +$528K | ﹤0.01% | 3220 |
|
2022
Q4 | $5.68M | Buy |
780,414
+54,897
| +8% | +$400K | ﹤0.01% | 2989 |
|
2022
Q3 | $5.87M | Buy |
725,517
+76,851
| +12% | +$622K | ﹤0.01% | 2985 |
|
2022
Q2 | $3.18M | Sell |
648,666
-27,288
| -4% | -$134K | ﹤0.01% | 3319 |
|
2022
Q1 | $16M | Sell |
675,954
-21,957
| -3% | -$519K | ﹤0.01% | 2556 |
|
2021
Q4 | $12.3M | Buy |
697,911
+245,599
| +54% | +$4.34M | ﹤0.01% | 2790 |
|
2021
Q3 | $12.8M | Buy |
452,312
+140,087
| +45% | +$3.95M | ﹤0.01% | 2741 |
|
2021
Q2 | $3.27M | Buy |
312,225
+57,728
| +23% | +$605K | ﹤0.01% | 3428 |
|
2021
Q1 | $3M | Buy |
254,497
+15,048
| +6% | +$177K | ﹤0.01% | 3268 |
|
2020
Q4 | $2.8M | Buy |
239,449
+27,394
| +13% | +$321K | ﹤0.01% | 3230 |
|
2020
Q3 | $1.68M | Buy |
212,055
+4,957
| +2% | +$39.3K | ﹤0.01% | 3272 |
|
2020
Q2 | $3.79M | Buy |
207,098
+12,836
| +7% | +$235K | ﹤0.01% | 2903 |
|
2020
Q1 | $2.32M | Buy |
194,262
+155,213
| +397% | +$1.85M | ﹤0.01% | 2994 |
|
2019
Q4 | $650K | Buy |
+39,049
| New | +$650K | ﹤0.01% | 3483 |
|